Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$697,937
in 4 filings, $698K under 10b5-1 plans

Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-01 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Option exercise +2,250 59,596
2020-03-01 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Shares withheld for taxes −662 $20.84 $14K 58,934
2020-03-01 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Option exercise · Restricted Stock Unit Award −2,250 0
2020-03-01 FRATES JAMES M SVP, Alks Inc; CFO ALKS Option exercise +4,500 71,168
2020-03-01 FRATES JAMES M SVP, Alks Inc; CFO ALKS Shares withheld for taxes −1,323 $20.84 $28K 69,845
2020-03-01 FRATES JAMES M SVP, Alks Inc; CFO ALKS Option exercise · Restricted Stock Unit Award −4,500 0
2020-03-01 Brown Iain Michael SVP Finance & CAO, Alks Inc. Option exercise +2,250 39,243
2020-03-01 Brown Iain Michael SVP Finance & CAO, Alks Inc. Shares withheld for taxes −662 $20.84 $14K 38,581
2020-03-01 Brown Iain Michael SVP Finance & CAO, Alks Inc. Option exercise · Restricted Stock Unit Award −2,250 0
2020-02-24 Wysenski Nancy Director Purchase +6,940 $19.65 $136K 11,242
2020-02-21 Hopkinson Craig C. EVP R&D, Chief Medical Officer Option exercise +6,875 15,955
2020-02-21 Hopkinson Craig C. EVP R&D, Chief Medical Officer Option exercise · Restricted Stock Unit Award −6,875 20,625

Page 75 of 75 · 1,492 trades